DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Cowen & Co. Initiates Coverage On Revolution Medicines with Outperform Rating

Cowen & Co. initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Outperform rating.

Benzinga · 03/09/2020 17:19

Cowen & Co. initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Outperform rating.